R C Seeger

851 total citations
20 papers, 659 citations indexed

About

R C Seeger is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, R C Seeger has authored 20 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in R C Seeger's work include Neuroblastoma Research and Treatments (18 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). R C Seeger is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). R C Seeger collaborates with scholars based in United States, United Kingdom and Spain. R C Seeger's co-authors include C. Patrick Reynolds, Katherine K. Matthay, Alice L. Yu, Ruth Hsiao, Daniel T. O’Connor, John P. Huberty, Robert S. Hattner, Kenneth B. DeSantes, Vivian Weinberg and David C. Price and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

R C Seeger

20 papers receiving 630 citations

Peers

R C Seeger
D Beck Switzerland
James N. Gerson United States
Brodeur Gm United States
Justine N. McCutcheon United States
Nicholas Murray United Kingdom
Sheena C. Tenney United States
Valeria Smith United States
Sivasish Sindiri United States
Surya P. Rednam United States
Ali Fuat Okuducu Germany
D Beck Switzerland
R C Seeger
Citations per year, relative to R C Seeger R C Seeger (= 1×) peers D Beck

Countries citing papers authored by R C Seeger

Since Specialization
Citations

This map shows the geographic impact of R C Seeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R C Seeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R C Seeger more than expected).

Fields of papers citing papers by R C Seeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R C Seeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R C Seeger. The network helps show where R C Seeger may publish in the future.

Co-authorship network of co-authors of R C Seeger

This figure shows the co-authorship network connecting the top 25 collaborators of R C Seeger. A scholar is included among the top collaborators of R C Seeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R C Seeger. R C Seeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehmann, Rainer, et al.. (2011). Richtlinien bezüglich Fahreignung bei Diabetes mellitus. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 11(15). 3 indexed citations
2.
Shusterman, Suzanne, W. B. London, S. D. Gillies, et al.. (2008). Anti-neuroblastoma activity of hu14.18-IL2 against minimal residual disease in a Children’s Oncology Group (COG) phase II study. Journal of Clinical Oncology. 26(15_suppl). 3002–3002. 11 indexed citations
3.
Villablanca, Judith G., R C Seeger, Hiro Shimada, et al.. (2005). Outcome of high risk (HR) stage 3 neuroblastoma (NB) with myeloablative therapy and 13-cis-retinoic Acid. Journal of Clinical Oncology. 23(16_suppl). 8503–8503. 3 indexed citations
4.
Hank, Jacquelyn A., Mark R. Albertini, Alexander Sternberg, et al.. (2004). A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group. Journal of Immunotherapy. 27(6). S55–S56. 3 indexed citations
5.
London, Wendy B., et al.. (2004). Recurrent neuroblastoma: Randomized treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A POG/CCG Intergroup Study. Journal of Clinical Oncology. 22(14_suppl). 8512–8512. 4 indexed citations
6.
London, Wendy B., et al.. (2004). Recurrent neuroblastoma: Randomized treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A POG/CCG Intergroup Study. Journal of Clinical Oncology. 22(14_suppl). 8512–8512. 5 indexed citations
7.
Wang, Ying, et al.. (2000). Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors.. PubMed. 6(2). 551–8. 22 indexed citations
8.
Wiedemann, G., R. Zschaber, Susanna Hegewisch‐Becker, et al.. (1999). Two Oral Trofosfamide Schedules in Elderly Patients with Refractory Non-Hodgkin‘s Lymphoma. Oncology Research and Treatment. 22(2). 134–138. 7 indexed citations
9.
Matthay, Katherine K., Kenneth B. DeSantes, B.H. Hasegawa, et al.. (1998). Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.. Journal of Clinical Oncology. 16(1). 229–236. 163 indexed citations
10.
Seeger, R C, et al.. (1995). Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vector.. PubMed. 2(3). 171–81. 15 indexed citations
11.
12.
Matthay, Katherine K., R C Seeger, C. Patrick Reynolds, et al.. (1994). Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.. Journal of Clinical Oncology. 12(11). 2382–2389. 85 indexed citations
13.
Campbell, Laura, R C Seeger, Richard E. Harris, Judith G. Villablanca, & Katherine K. Matthay. (1993). Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.. Journal of Clinical Oncology. 11(4). 623–629. 23 indexed citations
14.
Crabbe, David, Jeffrey H. Peters, & R C Seeger. (1992). Rapid Detection of MYCN Gene Amplification in Neuroblastomas Using the Polymerase Chain Reaction. Diagnostic Molecular Pathology. 1(1). 229–234. 35 indexed citations
15.
Hsiao, Ruth, R C Seeger, Alice L. Yu, & Daniel T. O’Connor. (1990). Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.. Journal of Clinical Investigation. 85(5). 1555–1559. 97 indexed citations
16.
Gj, D'Angio, Evans Ae, R C Seeger, et al.. (1985). Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.. PubMed. 175. 557–63. 21 indexed citations
17.
Brodeur, G M, R C Seeger, Manfred Schwab, H E Varmus, & J. Michael Bishop. (1985). Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage.. PubMed. 175. 105–13. 29 indexed citations
18.
19.
Sather, Harland N., et al.. (1983). RAISED NEURON-SPECIFIC ENOLASE IN SERUM OF CHILDREN WITH METASTATIC NEUROBLASTOMA. The Lancet. 322(8346). 361–363. 125 indexed citations
20.
Danon, Yehuda L., et al.. (1980). Variability in DNA distributions of human neuroblastomas after cyclophosphamide.. PubMed. 64(12). 1275–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Beck Breakdown of academic impact, for papers by James N. Gerson Breakdown of academic impact, for papers by Brodeur Gm Breakdown of academic impact, for papers by Justine N. McCutcheon Breakdown of academic impact, for papers by Nicholas Murray Breakdown of academic impact, for papers by Sheena C. Tenney Breakdown of academic impact, for papers by Valeria Smith Breakdown of academic impact, for papers by Sivasish Sindiri Breakdown of academic impact, for papers by Surya P. Rednam Breakdown of academic impact, for papers by Ali Fuat Okuducu
Rankless by CCL
2026